TERMINATION OF LICENSE AGREEMENT UCSD CONTROL #2008-03-0536
Exhibit 10.2
TERMINATION OF LICENSE AGREEMENT UCSD CONTROL #▇▇▇▇-▇▇-▇▇▇▇
This termination agreement (“Termination Agreement”) is made by and between Navidea Biopharmaceuticals, Inc., a Delaware corporation having an address at ▇▇▇▇ ▇▇▇▇▇▇ ▇▇▇▇▇▇▇, ▇▇▇▇▇ ▇▇▇, ▇▇▇▇▇▇, ▇▇ ▇▇▇▇▇-▇▇▇▇ (“LICENSEE”) and The Regents of the University of California, a California corporation having its statewide administrative offices at ▇▇▇▇ ▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇, ▇▇▇▇▇▇▇, ▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇-▇▇▇▇ (“UNIVERSITY”), represented by its San Diego campus having an address at University of California, San Diego, Technology Transfer Office, Mail Code 0910, ▇▇▇▇ ▇▇▇▇▇▇ ▇▇▇▇▇, ▇▇ ▇▇▇▇▇, ▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇-▇▇▇▇ (“UCSD”).
This Termination Agreement is effective on the date of the last signature (“Effective Date”).
RECITALS
WHEREAS, LICENSEE previously entered a license agreement, UCSD Control #▇▇▇▇-▇▇-▇▇▇▇ effective April 9, 2008, as Neoprobe Corporation for the commercial development of the invention disclosed in UCSD Disclosure Docket No. SD1998-088 and titled “Macromolecular Carrier for Drug and Diagnostic Agent Delivery” made in the course of research at UCSD by ▇▇. ▇▇▇▇▇ ▇▇▇▇.
WHEREAS, LICENSEE changed its name from Neoprobe Corporation to Navidea Biopharmaceuticals, Inc. effective January 5, 2012.
WHEREAS, LICENSEE and UNIVERSITY both desire, for their mutual benefit, to terminate the agreement UCSD Control #▇▇▇▇-▇▇-▇▇▇▇ effective as of the Effective Date.
NOW, THEREFORE, the LICENSEE and UNIVERSITY thereby agree to terminate agreement UCSD Control #▇▇▇▇-▇▇-▇▇▇▇ and further agree that the only provisions of that agreement that shall survive termination are:
Paragraph 7.4 (Disposition of Licensed Products on Hand);
Paragraph 8.1(c), and 8.1(d) (Limited Warranty);
Paragraph 8.2 (Indemnification);
Article 9 (USE OF NAMES AND TRADEMARKS);
Paragraph 10.2 (Secrecy); and
Paragraph 10.6 (Governing Laws).
IN WITNESS WHEREOF, both UNIVERSITY and LICENSEE have executed this Termination Agreement, in duplicate originals, by their respective and duly authorized officers on the day and year written.
NAVIDEA BIOPHARMACEUTICALS, INC. THE REGENTS OF THE
UNIVERSITY OF CALIFORNIA
By: /s/ ▇▇▇▇▇▇ ▇. Tulip By: /s/ ▇▇▇▇▇▇▇ ▇. ▇▇▇▇▇▇
Name: ▇▇▇▇▇▇ ▇. Tulip, PhD ▇▇▇▇▇▇▇ ▇. ▇▇▇▇▇▇, Ph.D.
Title: President & Chief Business Officer Associate Director-Technology Transfer
Date: 11 July 2014 Date: July 14, 2014